Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

IBW Financial Corporation (IBWC)

Compare

43.00

0.00

(0.00%)

At close: March 11 at 4:00:00 PM EDT

Chinese tech stock Hesai jumps 50% on Mercedes-Benz contract

Hesai Group (HSAI) shares surge after reports that Mercedes-Benz (MBGAF) will equip its upcoming smart driving cars with the Chinese lidar developer's technology, according to reports from Reuters. Julie Hyman and Josh Lipton take a closer look at the monumental stock move. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Naomi Buchanan.

Yahoo Finance Video 12 hours ago

MBGAF

MBGYY

HSAI
Kohl's stock plummets as sales drop, guidance widely misses estimates amid turnaround efforts

The department store is attempting another turnaround.

Yahoo Finance 17 hours ago

KSS

M
Puma Drops After Predicting a Tough Year for Sneaker Sales

(Bloomberg) -- Puma SE shares plunged after the sneaker maker disappointed investors for the second time in seven weeks with softer-than-expected results and forecast another year of slow growth.Most Read from BloombergNYC Congestion Pricing Toll Gains Support Among City ResidentsTrump DEI Purge Hits Affordable Housing GroupsElectric Construction Equipment Promises a Quiet RevolutionWhere New York City's Zoning Reform Will Add HousingOpen Philanthropy Launches $120 Million Fund To Support YIMBY

Bloomberg 1 hour ago

PUMSY
3 Growth Stocks That Could Help Make You a Fortune

The Trade Desk, Supermicro, and Palo Alto Networks all have plenty of room to grow.

Motley Fool 1 hour ago

PANW

TTD

SMCI
Rheinmetall Annual Sales Soar to Record $10.65 Billion, But Miss Target

While 2024 sales grew 35%, boosted by increased demand, there was a dip in sales at its power systems and trade divisions at the start of of the year.

The Wall Street Journal 1 hour ago

RNMBF

RNMBY
Rheinmetall expects strong 2025 sales in Europe's 'era of rearmament'

BERLIN (Reuters) -Rheinmetall, a major beneficiary of Europe's renewed push to invest in defence, said on Wednesday it expects significant sales growth in 2025 and promised to update guidance after recent geopolitical developments are taken into account. The German defence company expects sales to grow by 25% to 30% in 2025 as a result of the Russian invasion of Ukraine and the decoupling of the United States from Europe, it said. At the same time, Europe's top ammunition maker anticipates an improvement in the operating result and an operating margin of around 15.5%, slightly above the 2024 level of 15.2%.

Reuters 2 hours ago

RNMBY
Stitch Fix Inc (SFIX) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth

Despite a decline in revenue and active clients, Stitch Fix Inc (SFIX) shows resilience with improved margins and strategic investments for future growth.

GuruFocus.com 2 hours ago

SFIX
EU Hits Back as U.S. Steel and Aluminum Tariffs Take Effect

The 25% global levy was imposed by the Trump administration after the U.S. and Canada backed away from additional measures. The European Union responded with retaliatory tariffs.

The Wall Street Journal 2 hours ago

X
Zara Parent Inditex Says Expansion Plan on Track Amid Fierce Competition in Fast Fashion

The owner of fashion brand Zara said store and online sales rose 4% at constant currency compared with the prior-year period.

The Wall Street Journal 2 hours ago

IDEXF

IDEXY
Kohl's Corp (KSS) Q4 2024 Earnings Call Highlights: Navigating Sales Declines and Strategic ...

Kohl's Corp (KSS) faces challenges with declining sales but remains focused on strategic brand and omnichannel improvements to drive future growth.

GuruFocus.com 2 hours ago

KSS
Hesai Group (HSAI) Q4 2024 Earnings Call Highlights: Record Lidar Shipments and Strong ...

Hesai Group (HSAI) reports robust growth in 2024 with over 500,000 Lidar units shipped and projects significant expansion in 2025.

GuruFocus.com 2 hours ago

HSAI
Roche Agrees to Develop Weight-Loss Therapy With Zealand Pharma

The companies agreed to share profits for the therapy equally in the U.S. and Europe, but Roche will have exclusive rights to commercialization in the rest of the world.

The Wall Street Journal 2 hours ago

RHHBF

RHHBY

RHHVF
Zara owner Inditex reports slower start to first quarter

ARTEIXO, Spain (Reuters) -Zara owner Inditex on Wednesday reported a slower start to its first quarter starting February 1 after full-year sales and profit met analysts' expectations, raising questions around its ability to keep building on rapid recent growth. Inditex's strong sales as Zara took market share from rivals such as H&M have driven a strong run in its share price, now more than double where it was three years ago, but the stock has struggled recently as concerns grow around weakening consumer demand. Sales were up just 4% in currency-neutral terms over the February 1 to March 10 period, Inditex said, compared to 11% growth a year ago.

Reuters 2 hours ago

ITX.MC
Roche secures Zealand obesity drug candidate for up to $5.3 billion

ZURICH (Reuters) -Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, as the Swiss drugmaker seeks to boost its prospects in the booming weight-loss market. The agreement covering the compound petrelintide, announced by Roche on Wednesday, marks renewed efforts to catch up with weight-loss market leaders Novo Nordisk and Eli Lilly. Under the accord, Zealand will receive $1.65 billion upfront with the possibility of milestone payments taking the total sum to $5.3 billion, depending mainly on phase 3 trials and sales development, Roche said.

Reuters 3 hours ago

ROG.SW

ZEAL.CO
EHang Reports Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

Record-high quarterly and annual revenues, up 190.2% and 288.5% YoY, respectivelyRecord-high quarterly and annual delivery volume, 216 units in 20241st year and 3rd consecutive quarter of non-GAAP profitability11st year and 5th consecutive quarter of positive operating cash flowFiscal year 2025 revenues expected to be around RMB900 million, up 97% YoY GUANGZHOU, China, March 11, 2025 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading Urban Air

GlobeNewswire 3 hours ago

EH
The most popular stocks for investors in February

February proved to be another eventful month for investors, as escalating trade tensions and geopolitical risks sparked further volatility in markets.

Yahoo Finance UK 3 hours ago

GBPUSD=X

USD=X

GBP=X
Roche enters into an exclusive collaboration & licensing agreement with Zealand Pharma to co-develop and co-commercialise petrelintide as a potential foundational therapy for people with overweight and obesity

Agreement allows for a range of potentially best-in-class therapy options as monotherapy and fixed dose combination with Roche`s lead incretin asset CT 388Collaboration will complement Roche's portfolio in the field of cardiovascular, renal, and metabolic (CVRM) diseasesObesity is a heterogeneous disease with over 200 related comorbidities, including cardiovascular and metabolic diseases, and is expected to impact over 4 billion people globally by 2035 Basel, 12 March 2025 - Roche (SIX: RO, ROG;

GlobeNewswire 3 hours ago

RHHBF

RHHBY

RHHVF
Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesity

Company announcement – No. 4 / 2025 Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesity The companies will co-develop and co-commercialize petrelintide monotherapy and potential combination products, including petrelintide/CT-388, in the U.S. and EuropeZealand Pharma will receive upfront cash payments of USD 1.65 billion, including USD 1.4 billion due at closing

GlobeNewswire 3 hours ago

ZLDPF
Q4 2024 Kohls Corp Earnings Call

Q4 2024 Kohls Corp Earnings Call

Thomson Reuters StreetEvents 4 hours ago

KSS
Why Teradyne, Inc. (TER) Went Down on Tuesday

We recently compiled a list of the 10 Stocks Battered by Bearish Outlooks. In this article, we are going to take a look at where Teradyne, Inc. (NASDAQ:TER) stands against the other stocks. Ten firms ended Tuesday suffering a sell-off, as investor sentiment continues to be dampened by macroeconomic uncertainties and bearish outlooks from analysts and […]

Insider Monkey 4 hours ago

TER

Performance Overview

Return	IBWC	S&P 500
YTD	+2.38%	-5.26%
1-Year	+170.36%	+8.87%
3-Year	+98.14%	+32.53%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

IBW Financial Corporation (IBWC)

Related News

Chinese tech stock Hesai jumps 50% on Mercedes-Benz contract

Kohl's stock plummets as sales drop, guidance widely misses estimates amid turnaround efforts

Puma Drops After Predicting a Tough Year for Sneaker Sales

3 Growth Stocks That Could Help Make You a Fortune

Rheinmetall Annual Sales Soar to Record $10.65 Billion, But Miss Target

Rheinmetall expects strong 2025 sales in Europe's 'era of rearmament'

Stitch Fix Inc (SFIX) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth

EU Hits Back as U.S. Steel and Aluminum Tariffs Take Effect

Zara Parent Inditex Says Expansion Plan on Track Amid Fierce Competition in Fast Fashion

Kohl's Corp (KSS) Q4 2024 Earnings Call Highlights: Navigating Sales Declines and Strategic ...

Hesai Group (HSAI) Q4 2024 Earnings Call Highlights: Record Lidar Shipments and Strong ...

Roche Agrees to Develop Weight-Loss Therapy With Zealand Pharma

Zara owner Inditex reports slower start to first quarter

Roche secures Zealand obesity drug candidate for up to $5.3 billion

EHang Reports Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

The most popular stocks for investors in February

Roche enters into an exclusive collaboration & licensing agreement with Zealand Pharma to co-develop and co-commercialise petrelintide as a potential foundational therapy for people with overweight and obesity

Zealand Pharma and Roche enter collaboration and license agreement to co-develop and co-commercialize petrelintide as a future foundational therapy for people with overweight and obesity

Q4 2024 Kohls Corp Earnings Call

Why Teradyne, Inc. (TER) Went Down on Tuesday

Performance Overview